Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

Covagen raises $63m for targeted antibody work

Authored by Karl Simpson The Swiss biotechnology company Covagen announced that it had successfully completed a second round of funding (series B) by raising $63m. The funding came from existing investors such as Novartis and new investors such as Ascent … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Symphogen’s Monoclonal Antibody Technology Making Waves

Authored by James Sheppard The Danish biotechnology company Symphogen has been in the spotlight of late with a wave of positive clinical and financial news. Symphogen are developing monoclonal antibodies (mABs) for the treatment of various oncological indications including colorectal, … Continue reading

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Merus Biopharmaceuticals building to future with strong pipeline

Authored by James Sheppard Merus Biopharmaceuticals, the Dutch biotechnology company has seen a wave of positive news of late and is now promising to push on towards clinical studies. Merus is developing novel drugs that combine the benefits on monoclonal … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Billionaires send Ganymed racing through clinic

Authored by James Sheppard The Germany biotechnology company Ganymed has announced that it had successfully raised $60m in a new venture round to advance the ongoing phase IIa and phase IIb study of IMAB362 for gastroesophageal cancer. Ganymed has now … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

CFO appointments no longer just a numbers game

Authored by Karl Simpson AstraZeneca’s CEO, Pascal Soriot, recently said when announcing the newly appointed CFO Marc Dunoyer that he offered a blend of strategic thinking and financial expertise. Mr. Dunoyer joined AstraZeneca earlier this year from GSK where he … Continue reading

Posted in General, Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Open Innovation could spur diversity

Authored by Karl Simpson Open Innovation is the new wave. The accepted remedy to the innovation black-hole experienced in drug discovery and development over recent years. It is a paradigm shift. Suddenly, the R&D heavyweights are throwing away their R&D … Continue reading

Posted in General, Pharmaceutical business, Workplace Diversity | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Diversity agenda still lagging in the biotechnology market

Authored by Karl Simpson October saw the release of the new World Economic Forum’s report on the Global Gender Gap. Once again, the list of top 10 places to be a woman in business seems to be dominated by the … Continue reading

Posted in General, Recruitment Market, Workplace Diversity | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap